Arena Pharmaceuticals - 48 Year Dividend History | ARNA

Historical dividend payout and yield for Arena Pharmaceuticals (ARNA) since 1971. The current TTM dividend payout for Arena Pharmaceuticals (ARNA) as of December 12, 2019 is $0.00. The current dividend yield for Arena Pharmaceuticals as of December 12, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.350B $0.018B
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ (lorcaserin HCl), their internally discovered drug for chronic weight management, is their first and only drug approved by any regulatory agency for marketing. BELVIQ was approved by the US Food and Drug Administration, or FDA, for marketing in the United States, and was made available by prescription in June 2013 to adults who are overweight with a comorbidity or obese. They are exploring BELVIQ for possible new indications, using different formulations, and in combination with other drugs.
Stock Name Country Market Cap PE Ratio